Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Efficacy and safety of nivolumab-based therapies in first-line and Relapsed/Refractory Hodgkin lymphoma

Anas Nasir, Ahmed Raza, Muhammad Rafay Paracha, zahra ali haque, Dania Hussain, Amal Khan, Suleman Saeed, Hamid Tariq, hafiz waqas naseer, Muhammad Ali Bin Jabir, Haider Imran, Muhammad Ali, Ateeb Parvez, Muhammad Mirza, Muhammad Saad Arshad Arain, Rahima Tauqeer

Blood (2025) 146 (Supplement 1): 7140.

https://doi.org/10.1182/blood-2025-7140

Published: 2025

Journal Articles

Diagnostic disparities in sickle cell disease: Rates and implications

Muhammad Saad Khan, Nicole Bohnker, Joshua Wolfe, Collins Odhiambo, Kay Linn Saving, Jennifer Light

Blood (2025) 146 (Supplement 1): 7978.

https://doi.org/10.1182/blood-2025-7978

Published: 2025

Journal Articles

Acute Myeloid Leukemia-associated pneumonia mortality trends (1999–2023) and ARIMA-based projections through 2050 in geriatric u.S. adults

Haseeb Tareen, Allah Dad, Muhammad Arham, Saif Ali Khan, Ali Zubair, Muhammad Saad Khan, Muhammad Taha Altaf, Shahzaib Maqbool, Kinza Bakht, Fahad Saleem, Hafsa Ahmed, Safi Ur Rehman Daim, Manya Kumar, Venumadhavi Gogineni

Blood (2025) 146 (Supplement 1): 6932.

https://doi.org/10.1182/blood-2025-6932

Published: 2025

Journal Articles

Patterns of care in second line management of nodal peripheral T-cell lymphoma from the lymphoma epidemiology of outcomes (LEO) and molecular epidemiology resource (MER) prospective cohort Study

Blood (2025) 146 (Supplement 1): 3635.

https://doi.org/10.1182/blood-2025-3635

Published: 2025

Journal Articles

Diagnostic and therapeutic patterns in cutaneous T-cell lymphomas (CTCL): Real-world data from the lymphoma epidemiology outcome-molecular epidemiology resource (LEO-MER) prospective cohort study.

Muhammad Saad Hamid, Ashley McCook-Veal, Jeffrey Switchenko, Neha Mehta-Shah, Neha Akkad, Luis Malpica, Danielle Wallace, Evelyn Orlando, Jia Ruan, Brooj Abro, Melissa Larson, James Cerhan, Christopher Flowers, Georgios Pongas, Eric Mou, N. Nora Bennani, Pamela Allen

Blood (2025) 146 (Supplement 1): 1870.

https://doi.org/10.1182/blood-2025-1870

Published: 2025

Journal Articles

Efficacy and Safety of CHO(E)P Plus Novel Agents in Treatment-Naïve Peripheral T-Cell Lymphoma: Systemic Review and Meta-Analyses

Sarah A. Hashimi, Simranjit Sekhon, Mary Klacik Webster, Chenhao Zhao, Hilary Jasmin, Zhu Wang, Muhammad Saad Hamid

Blood (2024) 144 (Supplement 1): 6391.

https://doi.org/10.1182/blood-2024-202111

Published: 2024

Journal Articles

Treatment Trends and Outcomes of Allogeneic Haematopoeitic Cell Transplantation (HCT) in Acute Lymphoblastic Leukaemia (ALL) in Resource Restricted Setting; A Pakistan Blood and Marrow Transplant Group (PBMT) Study

Syed Waqas Imam Bokhari, Mehreen Ali Khan, Danyal Ghani, Natasha Ali, Aisha Jamal, Muhammad Saad, Uzma Zaidi, Usman Ahmad, Bushra Ahsan, Sana Khurram, Farrukh Ali Khan, Syed Nasir Abbas Bukhari, Muhammad Nadeem, Lavita Kumari, Tariq Ghafoor, Muhammad Ayaz Mir, Munira Shabbir-Moosajee, Raheel Iftikhar, Tariq Mahmood Satti

Blood (2024) 144 (Supplement 1): 7436.

https://doi.org/10.1182/blood-2024-208772

Published: 2024

Journal Articles

Real-World Treatment Patterns and Outcomes of Patients (Pts) with Follicular Lymphoma (FL) Who Experienced Progression of Disease within 24 Months (POD24)

Muhammad Saad Hamid, Claire Bai, Chelsea Perelgut, Helena Yelovich, Christina M. Zettler, Laura L. Fernandes, Andrew J. Belli, Eric Hansen, Ching-Kun Wang

Blood (2023) 142 (Supplement 1): 3781.

https://doi.org/10.1182/blood-2023-182064

Published: 2023

Journal Articles

Efficacy and Safety Profile of CPX-351 in Secondary Acute Myeloid Leukemia (sAML): A Systematic Review

Ahmed Ibrahim, Muhammad Abdullah Yousaf, Mariam Ikram, Huma Khalid, . Anum, Omar A Safdar, Zain Anwer, Fatima Faraz, Mohammad Rehman, Muhammad Saad

Blood (2023) 142 (Supplement 1): 2898.

https://doi.org/10.1182/blood-2023-187301

Published: 2023

Journal Articles

Comprehensive Analysis of Structural and Social Determinants of Health Leading to Delays in Seeking Hematologic Care: Survey of an Underserved Population with Hematologic Malignancies

Laura Quillen, Noura Elsedawy, Terrence Jones, Brion Randolph, Muhammad Saad Hamid, Swapna Thota

Blood (2023) 142 (Supplement 1): 910.

https://doi.org/10.1182/blood-2023-174770

Published: 2023

Journal Articles

Efficacy and Safety of Nelarabine in Different Age Groups with T-Cell Hematological Malignancies: A Systematic Review of Clinical Trials

Wajeeha Aiman, Zainab Omar, Muhammad Saad Anwar, Sarah Sarwat Uzma Munawar, Sumaiya Asfund, Yusra Arooj, Shadma Fatima, Hina Zubair, Huda Khan, Rabiya Niaz, Taimoor Jamil, Ayesha Anwar, Muhammad Ashar Ali

Blood (2022) 140 (Supplement 1): 11696–11697.

https://doi.org/10.1182/blood-2022-167981

Published: 2022

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Abdul Rafae, MD, Moazzam Shahzad, MD, Muhammad Saad Farooqi, MDMBBS, Sundas Ali, MBBS, MD, Saad Javed, MD, Richi Kashyap, MD, Shaha Nabeel, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-141761

Published: 2020

Journal Articles

Role of Adoptive T- Cell Therapy in Post Hematopoietic Stem Cells Transplant Viral Infections-: A Systemic Review

Hassaan Imtiaz, MD, Muhammad Saad Farooqi, MDMBBS, Unaiza Faizan, MD, Saad Ur Rehman, MD, Muhammed Hamza Arshad, MD, Ali Shahbaz Baloch, MD, Syed Shahnawaz Hashmi, MD, Abdullah Jamal, MBBS, Taimoor Jaffar Ali, MBBS, Ali Younas Khan, MD, Zahoor Ahmed, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Qasim Khurshid, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 14–16.

https://doi.org/10.1182/blood-2020-139284

Published: 2020

Journal Articles

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

Muhammad Saad Farooqi, MDMBBS, Unaiza Faizan, MD, Saad Ur Rahman, MBBS, Hassaan Imtiaz, MD, Muhammed Hamza Arshad, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Muhammad Ali Aziz, MD, Ali Jaan, MD, Ali Shahbaz Baloch, MD, Naurez Qasim, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137139

Published: 2020

Journal Articles

Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- a Systematic Review

Unaiza Faizan, MD, Muhammad Saad Farooqi, MDMBBS, Hassaan Imtiaz, MD, Muhammad Yasir Anwar, Muhammad Khawar Sana, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Abdul Jabbar Dar, MD, Hamza Hashmi, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-141078

Published: 2020

Journal Articles

Efficacy of Chemotherapeutic Regimens for Mantle Cell Lymphoma: A Systematic Review of Phase III Trials

Ali Jaan, MD, Muhammad Tayyeb, MD, Farhan Khalid, MBBS, Muhammad Khawar Sana, MD, Zahoor Ahmed, MD, Muhammad Saad Farooqi, MDMBBS, Mydah Sajid Hashmi, MD, Syed Maaz Abdullah, MBBS, Sundas Ali, Umar Farooque, MBBS, Saad Javed, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141181

Published: 2020

Journal Articles

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Arshia Akbar, MDMBBS, Waqas Khan, Zunairah Shah, MBBS, Muhammad Yasir Anwar, Muhammad Ali Aziz, MD, Zahoor Ahmed, MD, Muhammad Saad Farooqi, MDMBBS, Ali Shahbaz Baloch, MD, Mydah Sajid Hashmi, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Saman Bahram, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-137152

Published: 2020

Journal Articles

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Muhammad Tayyeb, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Sana Irfan Khan, MD, Richi Kashyap, MD, Saad Javed, MD, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138750

Published: 2020

Journal Articles

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Sobia Aamir, MDFCPS, Richi Kashyap, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Israr Khan, Arshia Akbar, MDMBBS, Waqas Khan, Muhammad Tayyeb, MD, Sundas Ali, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-138964

Published: 2020

Journal Articles

A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Ali Jaan, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Atif Irfan Khan, MD, Richi Kashyap, MD, Anam Khan, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138718

Published: 2020

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Efficacy and safety of nivolumab-based therapies in first-line and Relapsed/Refractory Hodgkin lymphoma

Diagnostic disparities in sickle cell disease: Rates and implications

Acute Myeloid Leukemia-associated pneumonia mortality trends (1999–2023) and ARIMA-based projections through 2050 in geriatric u.S. adults

Patterns of care in second line management of nodal peripheral T-cell lymphoma from the lymphoma epidemiology of outcomes (LEO) and molecular epidemiology resource (MER) prospective cohort Study

Diagnostic and therapeutic patterns in cutaneous T-cell lymphomas (CTCL): Real-world data from the lymphoma epidemiology outcome-molecular epidemiology resource (LEO-MER) prospective cohort study.

Efficacy and Safety of CHO(E)P Plus Novel Agents in Treatment-Naïve Peripheral T-Cell Lymphoma: Systemic Review and Meta-Analyses

Treatment Trends and Outcomes of Allogeneic Haematopoeitic Cell Transplantation (HCT) in Acute Lymphoblastic Leukaemia (ALL) in Resource Restricted Setting; A Pakistan Blood and Marrow Transplant Group (PBMT) Study

Real-World Treatment Patterns and Outcomes of Patients (Pts) with Follicular Lymphoma (FL) Who Experienced Progression of Disease within 24 Months (POD24)

Efficacy and Safety Profile of CPX-351 in Secondary Acute Myeloid Leukemia (sAML): A Systematic Review

Comprehensive Analysis of Structural and Social Determinants of Health Leading to Delays in Seeking Hematologic Care: Survey of an Underserved Population with Hematologic Malignancies

Efficacy and Safety of Nelarabine in Different Age Groups with T-Cell Hematological Malignancies: A Systematic Review of Clinical Trials

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Role of Adoptive T- Cell Therapy in Post Hematopoietic Stem Cells Transplant Viral Infections-: A Systemic Review

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- a Systematic Review

Efficacy of Chemotherapeutic Regimens for Mantle Cell Lymphoma: A Systematic Review of Phase III Trials

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only